Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|August 7, 2017
Targeting Immune System Alterations in Hodgkin LymphomaNatalie S Grover, Barbara Savoldo
BMC Cancer|March 8, 2019
Challenges of driving CD30-directed CAR-T cells to the clinicNatalie S Grover, Barbara Savoldo
Pharmaceuticals (Basel, Switzerland)|September 23, 2015
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma TherapyNatalie S Grover, Steven I Park
Human Vaccines & Immunotherapeutics|November 15, 2023
Building safety into CAR-T therapyDaniel T Peters, Barbara Savoldo, Natalie S Grover
Blood|February 24, 2023
How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapyCristina Gutierrez, Tomas G Neilan, Natalie S Grover
Journal of Personalized Medicine|February 25, 2022
The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin LymphomaJeremy A Meier, Barbara Savoldo, Natalie S Grover
Hematology. American Society of Hematology. Education Program|December 9, 2023
The optimal management of relapsed and refractory Hodgkin lymphoma: post-brentuximab and checkpoint inhibitor failureNatalie S Grover, Christopher Dittus, Astha Thakkar, et al.
Journal of Oncology Practice|April 28, 2016
Young Men With Cancer Experience Low Referral Rates for Fertility Counseling and Sperm BankingNatalie S Grover, Allison M Deal, William A Wood, et al.
Leukemia & Lymphoma|September 16, 2020
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphomaTyler Walburn, Natalie S Grover, Colette J Shen, et al.
Pageof 5